Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.

Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.
复制标题

DOI:
10.1039/b819061e
复制
发表时间:
2009-05
影响因子:
4
通讯作者:
J. Spencer;Rajendra P. Rathnam;Mahesh Motukuri;A. Kotha;S. Richardson;A. Hazrati;J. Hartley;L. Male;M. Hursthouse
J. Spencer;Rajendra P. Rathnam;Mahesh Motukuri;A. Kotha;S. Richardson;A. Hazrati;J. Hartley;L. Male;M. Hursthouse
中科院分区:
化学2区
文献类型:
--
作者:
J. Spencer;Rajendra P. Rathnam;Mahesh Motukuri;A. Kotha;S. Richardson;A. Hazrati;J. Hartley;L. Male;M. Hursthouse

文献摘要

被引文献

相似文献

五元C,N-钯配体[(L)PdCl](2)(LH = 1-甲基-5-苯基-1H-1,4-苯并二氮杂卓-2(3 H)-酮)与1,2-乙烷双(二苯基膦)dppe反应,生成桥联钯配体。[Pd(2)L(2)(mu-dppe)Cl(2)] 3,其在溶液中通过(1)H和(31)P NMR光谱表征,在固态下通过X射线晶体学表征。在体外针对许多细胞系测试复合物3。例如,它抑制K562白血病细胞的IC(50)值为4.3 μ M(1小时暴露),并显示组织蛋白酶B抑制作用的IC(50)值为3 μ M。
The reaction of the five-membered C,N-palladacycle [(L)PdCl](2), where LH = 1-methyl-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one, with 1,2-ethanebis(diphenylphosphine), dppe, leads to the formation of the bridged palladacycle. [Pd(2)L(2)(mu-dppe)Cl(2)] 3, which was characterised in solution by (1)H and (31)P NMR spectroscopy and in the solid state by X-ray crystallography. Complex 3 was tested in vitro against a number of cell lines. For example, it inhibited K562 leukaemia cells with an IC(50) value of 4.3 microM (1 h exposure) and displayed cathepsin B inhibitory action with an IC(50) value of 3 microM.